Cargando…
Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial
BACKGROUND: While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vitamin D supplementation on psychiatric, cognitive an...
Autores principales: | Krivoy, Amir, Onn, Roy, Vilner, Yael, Hochman, Eldar, Weizman, Shira, Paz, Amir, Hess, Shmuel, Sagy, Roi, Kimhi-Nesher, Shiri, Kalter, Ehud, Friedman, Tal, Friedman, Zvi, Bormant, Gil, Trommer, Sharon, Valevski, Avi, Weizman, Abraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832639/ https://www.ncbi.nlm.nih.gov/pubmed/29226809 http://dx.doi.org/10.1016/j.ebiom.2017.11.027 |
Ejemplares similares
-
S41. SHORT- AND LONG-TERM OUTCOMES OF VITAMIN D SUPPLEMENTATION IN CLOZAPINE TREATED CHRONIC SCHIZOPHRENIA PATIENTS
por: Krivoy, Amir, et al.
Publicado: (2018) -
Clozapine blood level assessment using a point-of-care device:
feasibility and reliability
por: Kamhi-Nesher, Shiri, et al.
Publicado: (2022) -
Predicting Affect Classification in Mental Status Examination Using Machine Learning Face Action Recognition System: A Pilot Study in Schizophrenia Patients
por: Barzilay, Ran, et al.
Publicado: (2019) -
M152. IS MEDICAL SERVICES UTILISATION A MODERATING FACTOR OF EARLY EXCESS MORTALITY IN PATIENTS WITH SCHIZOPHRENIA
por: Krivoy, Amir, et al.
Publicado: (2020) -
EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline
por: Shor, Oded, et al.
Publicado: (2021)